NR4A1 and triple-negative breast carcinoma: The general lack of detectable KLK7 expression fits well to earlier studies reporting downregulation of KLK7 mRNA in breast cancers [39, 40], but there are also studies suggesting that KLK7 can be upregulated specifically in hormone receptor negative [41] and triple negative breast cancers [17].